Adrenal hyperplasia due to 21 hydroxylase deficiency is treated with low dose:
**Core Concept**
21 hydroxylase deficiency is a genetic disorder affecting the adrenal glands, leading to an inability to produce cortisol and aldosterone. This results in an overproduction of androgens, causing virilization in affected individuals. The condition is treated with glucocorticoids and mineralocorticoids to replace deficient hormones.
**Why the Correct Answer is Right**
The primary treatment for 21 hydroxylase deficiency involves the use of glucocorticoids, such as dexamethasone or prednisone, to suppress ACTH production and subsequently reduce androgen overproduction. Low-dose glucocorticoids are used to minimize side effects while effectively managing the condition. This approach also involves the administration of mineralocorticoids, like fludrocortisone, to replace aldosterone.
**Why Each Wrong Option is Incorrect**
**Option A:** Glucagon is not used in the treatment of 21 hydroxylase deficiency. It is primarily involved in glucose metabolism and has no direct role in managing this condition.
**Option B:** Insulin is not used in the treatment of 21 hydroxylase deficiency. It is involved in glucose regulation and has no direct role in managing this condition.
**Option C:** Aldosterone antagonists, like spironolactone, are not used to treat 21 hydroxylase deficiency. They are actually used to block the effects of aldosterone in conditions like congestive heart failure.
**Clinical Pearl / High-Yield Fact**
It is essential to note that the treatment of 21 hydroxylase deficiency involves a delicate balance between glucocorticoid and mineralocorticoid replacement. Dosing must be carefully managed to avoid excessive glucocorticoid effects while ensuring adequate mineralocorticoid replacement.
**Correct Answer:** D. Fludrocortisone.